ライフサイエンスコーパス: simultaneous pancreas-kidney transplantation

1 in centers using intravenous alemtuzumab in simultaneous pancreas kidney transplantation.

2 ility of rapid corticosteroid elimination in simultaneous pancreas kidney transplantation.

3 er cadaveric kidney transplantation alone or simultaneous pancreas-kidney transplantation.

4 rvival, and postsurgical complications after simultaneous pancreas-kidney transplantation.

5 survival rates now no longer trail those of simultaneous pancreas-kidney transplantation.

6 llowing donors after circulatory death (DCD) simultaneous pancreas-kidney transplantation.

7 laxis against CMV reactivation in kidney and simultaneous pancreas/kidney transplantation.

8 s azathioprine (AZA) in cyclosporine-treated simultaneous pancreas-kidney transplantations.

9 ere performed in 141 patients, including 126 simultaneous pancreas-kidney transplantations, 13 pancre

10 17 cases, retransplantation in 5 cases, and simultaneous pancreas-kidney transplantation after heart

11 ncreas after kidney transplant, the second a simultaneous pancreas kidney transplantation, and the th

12 Patients undergoing simultaneous pancreas-kidney transplantation are at risk

13 mediated rejection (AMR) of the kidney after simultaneous pancreas-kidney transplantation are unknown

14 on and its impact on long-term outcome after simultaneous pancreas-kidney transplantation are unknown

15 This study shows that simultaneous pancreas-kidney transplantation can restore

16 Pediatric donors are underutilized for simultaneous pancreas-kidney transplantation due to conc

17 Simultaneous pancreas-kidney transplantation has become

18 TD impacts pancreas graft survival after DCD simultaneous pancreas-kidney transplantation; however, i

19 With expanded recipient selection (primarily simultaneous pancreas-kidney transplantation) in patient

20 Late enteric bleeding in the setting of simultaneous pancreas-kidney transplantation is an uncom

21 revalence and severity of hypertension after simultaneous pancreas-kidney transplantation is limited

22 suggest that employing robotic assistance in simultaneous pancreas-kidney transplantation is safe.

23 f the perioperative anesthetic management of simultaneous pancreas-kidney transplantation is to maxim

24 V infection on patient and graft survival in simultaneous pancreas-kidney transplantations is unclear

25 tion (RSPK) and 124 undergoing open approach simultaneous pancreas-kidney transplantation (OSPK) duri

26 patients, with 16 receiving robotic-assisted simultaneous pancreas-kidney transplantation (RSPK) and

27 On multivariate analysis, pancreas after simultaneous pancreas-kidney transplantation/solitary pa

28 Simultaneous pancreas-kidney transplantation (SPK) ameli

29 from this consensus conference is that both simultaneous pancreas-kidney transplantation (SPK) and p

30 Successful simultaneous pancreas-kidney transplantation (SPK) impro

31 Simultaneous pancreas-kidney transplantation (SPK) may p

32 Fifteen type 1 diabetic patients undergoing simultaneous pancreas-kidney transplantation (SPK) under

33 types of pancreas transplant (PT) including simultaneous pancreas-kidney transplantation (SPK), panc

34 ednisone-based immunosuppressive regimen for simultaneous pancreas-kidney transplantation (SPK).

35 By category, 61 underwent simultaneous pancreas-kidney transplantation (SPK); 44 u

36 e retrospectively reviewed the records of 76 simultaneous pancreas-kidney transplantations (SPK) and

37 Simultaneous pancreas/kidney transplantation (SPK) has e

38 Simultaneous pancreas kidney transplantation (SPKT) is t

39 ective analysis of 130 patients submitted to simultaneous pancreas-kidney transplantation (SPKT) and

40 One of the alternative options to simultaneous pancreas-kidney transplantation (SPKT) for

41 Simultaneous pancreas-kidney transplantation (SPKT) is a

42 Simultaneous pancreas-kidney transplantation (SPKT) is t

43 We explore how simultaneous pancreas-kidney transplantation (SPKT) modi

44 The best induction agent for simultaneous pancreas-kidney transplantation (SPKT) rema

45 ions (PPFC) are a serious complication after simultaneous pancreas-kidney transplantation (SPKTx).

46 t that hypertension may be less common after simultaneous pancreas-kidney transplantation than after

47 rating time of 3 and 5 hr, respectively; the simultaneous pancreas kidney transplantation took 8 hr.

48 A total of 620 primary simultaneous pancreas-kidney transplantations were perfo